MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Electrode Impedance as a marker for “on” and “off” states in a Deep Brain Stimulation cohort: A pilot study

    W. Deeb, J. Shute, M. Okun (Gainesville, FL, USA)

    Objective: To determine the possible use of electrical impedance as an easily measured surrogate measure for clinical changes in patients with Parkinson’s disease (PD) with…
  • 2017 International Congress

    Tacrolimus induced parkinsonism presenting as freezing of gait and speech

    V. Paramanandam, H. DS, P.C. N (Chennai, India)

    Objective: Tacrolimus a calcineurin inhibitor is the most widely used immunosuppressant in post transplant patients. Mild adverse effects like tremors and parasthesia and occasionally major…
  • 2017 International Congress

    Metabolic syndrome: Its link with motor function of Parkinson’s disease (PD)

    H. Chan, Y. Cheung, D. Chau, V. Lo, C. Woo, S. Tse, T. Fung, W. Fong (Hong Kong, Hong Kong)

    Objective: To evaluate if metabolic risk factors can affect the motor function of PD patients Background: The etiology of PD remains unclear. It has been…
  • 2017 International Congress

    Anti-synuclein alpha antibodies and IL-1β at Parkinson Disease (PD).

    A. Boika, V. Ponomarev, H. Ivanchik (Minsk, Belarus)

    Objective: Determine a correlation between the levels of anti-synuclein alpha antibodies and IL-1β at serum and CSF of patients with PD. Background: PD is a…
  • 2017 International Congress

    Atypical and slowly progressive FTDP-17 caused by MAPT p.R406W mutations – similarities to AD and PSP.

    E. Ygland, D. van Westen, E. Englund, R. Rademakers, Z. Wszolek, K. Nilsson, C. Nilsson, O. Hansson, L. Gustafson, A. Puschmann (Lund, Sweden)

    Objective: We compiled clinical data of a new kindred with the MAPT c.1216C>T (p.Arg406Trp; R406W) mutation and systematically reviewed previously described cases with this mutation.…
  • 2017 International Congress

    Validation of actigraphy-derived sleep metrics in Parkinson’s disease (PD) patients and elderly controls, taking into account clinical and physiological status

    J. Munro, R. Wolz, D. Hill, Y. DAUVILLIERS (London, United Kingdom)

    Objective: To developed a novel sleep quantification method using raw actigraphy data from well characterized PD subjects and elderly controls with overnight PSG and home…
  • 2017 International Congress

    A qualitative study of the views and experience of people with Parkinson’s disease regarding their footwear

    A. Ashburn, M. Donnovan-Hall, J. Robison, M. Cole, C. Bowen, M. Burnett, L. Mamode, R. Pickering, D. Bader, D. Kunkel (Southampton, United Kingdom)

    Objective: A qualitative study to determine what people with Parkinson’s disease (PD) wear on their feet at home and outdoors and to increase our understanding…
  • 2017 International Congress

    Rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula: a case report

    T. Weissfeld, D. Kremens, J. McCall (Philadelphia, PA, USA)

    Objective: To report the case of a 75-year-old woman with rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula Background: Vascular malformations…
  • 2017 International Congress

    Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns

    M. Abu Snineh, R. Camicioli, J. Miyasaki (Jerusalen, Israel)

    Objective: We sought to assess decisional capacity (DC) for Goals of Care (GOC) using the MacArthur Competence Assessment Tool (MacCAT) for Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Effects of continuous apomorphine infusion on motor and nonmotor symptoms in Parkinson’s disease without cognitive deterioration

    J.-F. Houvenaghel, S. Drapier, J. Duprez, D. Drapier, M. Vérin (Rennes, France)

    Objective: The aim of the present study was to investigate the influence of apomorphine pump in Parkinson’s disease (PD) on motor and nonmotor symptoms, including…
  • « Previous Page
  • 1
  • …
  • 311
  • 312
  • 313
  • 314
  • 315
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley